# BioXcel Therapeutics, Inc. (BTAI)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BTAI/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 388.0K | $ -27.40M | $ -17.91M | $ 104.45M | $ -115.46M |
| 2025 | $ 657.4K | $ -71.57M | $ -58.99M | $ 109.66M | $ -95.46M |
| 2024 | $ 2.38M | $ -62.64M | $ -75.71M | $ 102.95M | $ -93.10M |
| 2023 | $ 1.49M | $ -193.60M | $ -167.62M | $ 101.38M | $ -56.51M |
| 2022 | $ 418.9K | $ -185.17M | $ -151.35M | $ 94.16M | $ 76.78M |
| 2021 | $ 0 | $ -127.10M | $ -98.18M | $ 1.40M | $ 221.67M |
| 2020 | $ 0 | $ -104.68M | $ -84.93M | $ 1.64M | $ 206.70M |
| 2019 | $ 0 | $ -42.55M | $ -36.33M | $ 1.03M | $ 26.90M |
| 2018 | $ 0 | $ -25.45M | $ -18.29M | $ 0 | $ 38.89M |
| 2017 | $ 0 | $ -6.11M | $ -2.96M | $ 371.0K | $ -982.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.90 |
| Liabilities / Eq | -1.25 |
| Current Ratio | 0.21 |

## Other views

- [Metrics](https://sponda.capital/en/BTAI.md)
- [Charts](https://sponda.capital/en/BTAI/charts.md)
- [Compare](https://sponda.capital/en/BTAI/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.